Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol in the context of substance use disorder treatment: A systematic review
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 17
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities
Lucia Grifoni, Giulia Vanti, Rosa Donato, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6070-6070
Open Access | Times Cited: 67
The therapeutic potential of purified cannabidiol
Saoirse E. O′Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
Brooks Johnson, Natalie Strand, John Raynak, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 530-530
Open Access | Times Cited: 1
Cannabidiol interactions with oxycodone analgesia in an operant orofacial cutaneous thermal pain assay following oral administration in rats
Ariana C. Brice‐Tutt, Niall Murphy, Barry Setlow, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 250, pp. 173968-173968
Closed Access
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access
Sleep and Substance Use: Exploring Reciprocal Impacts and Therapeutic Approaches
Christopher Bolling, M. Elizabeth Cardoni, J. Todd Arnedt
Current Psychiatry Reports (2025)
Closed Access
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
The neurobehavioural effects of cannabidiol in alcohol use disorder: study protocol for a double-blind, randomised, cross over, placebo-controlled trial
Tristan Hurzeler, Warren Logge, Joshua Watt, et al.
Contemporary Clinical Trials Communications (2024) Vol. 41, pp. 101341-101341
Open Access | Times Cited: 4
Cannabidiol (CBD): Confronting consumers’ expectations of therapeutic benefits with pharmacological reality
Bruno Revol, Julie Bagnolati, Joëlle Micallef, et al.
Therapies (2024) Vol. 79, Iss. 5, pp. 497-504
Closed Access | Times Cited: 3
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H. Murray, Brenda M. Gannon, Peter J. Winsauer, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 915-955
Open Access | Times Cited: 3
Investigating Cannabidiol’s Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review
Jes Sebastian Denis Völker, I. Micluția, Ramona-Cristina Vinași
European Journal of Pharmacology (2024) Vol. 979, pp. 176821-176821
Closed Access | Times Cited: 3
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Lindsay A. Lo, Caroline A. MacCallum, Kate Nanson, et al.
The Canadian Journal of Psychiatry (2023) Vol. 68, Iss. 8, pp. 557-571
Open Access | Times Cited: 8
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Luana B. Domingos, Nicole Rodrigues da Silva, Adriano José Maia Chaves Filho, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 13
Prevalence of cannabidiol use and correlates in U.S. adults
Namkee G. Choi, C. Nathan Marti, Bryan Y. Choi
Drug and Alcohol Dependence Reports (2024) Vol. 13, pp. 100289-100289
Open Access | Times Cited: 2
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach
Kayvan Ali Gharbi, Yvonne Bonomo, Christine Mary Hallinan
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4087-4087
Open Access | Times Cited: 5
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
João Ariel Bonar Fernandes, Renato Filev, Thiago Marques Fidalgo
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. 5, pp. 703-715
Closed Access | Times Cited: 5
Therapeutic Use and Other Reasons to Consume Cannabidiol: Insight from the French and Italian Contexts
Davide Fortin, Vincent Di Beo, Patrizia Carrieri, et al.
Journal of Psychoactive Drugs (2023), pp. 1-11
Closed Access | Times Cited: 5
Nanostructured Lipid Carriers Loaded with Cannabidiol Enhance Its Bioaccessibility to the Small Intestine
Lucia Grifoni, Giulia Vanti, Anna Rita Bilia
Nutraceuticals (2023) Vol. 3, Iss. 2, pp. 210-221
Open Access | Times Cited: 4
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder
Christopher Kudrich, Rebecca Chen, Meng Yuan, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Cannabidiol as a candidate pharmacotherapy for sleep disturbance in alcohol use disorder
Marie Gendy, Benício N. Frey, Michael Van Ameringen, et al.
Alcohol and Alcoholism (2023) Vol. 58, Iss. 4, pp. 337-345
Closed Access | Times Cited: 2
The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 435-455
Open Access
Cannabidiol Use Among Older Adults: Associations with Cannabis Use, Physical and Mental Health, and Other Substance Use
Namkee G. Choi, C. Nathan Marti, Bryan Y. Choi
Clinical Gerontologist (2024), pp. 1-13
Closed Access
Oxycodone Self-Administration in Female Rats is Enhanced by Δ9-tetrahydrocannabinol, but not by Cannabidiol, in a Progressive Ratio Procedure
Jacques D. Nguyen, Yanabel Grant, C. S. Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top